NCT01352962 2026-01-05
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
11 trialsNCT07184424 2025-09-19
Lenalidomide
Beijing Tsinghua Chang Gung Hospital
Phase NA Completed
NCT01547260 2022-08-22
LENAGEM
Karolinska University Hospital
Phase 1/2 Completed
NCT04326296 2020-05-15
The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
Henan Cancer Hospital
Phase 1 Unknown
NCT00717756 2020-02-17
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Brown University
Phase 2 Completed
NCT01545804 2017-02-09
Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 2 Completed
NCT01183663 2016-06-03
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01348503 2015-08-31
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Indiana University
Phase 1 Terminated
NCT00837031 2013-03-13
Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01126450 2012-03-20
Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer
Case Comprehensive Cancer Center
Phase 1 Terminated
NCT01166035 2010-07-20
TEXO
Medical University Innsbruck
Phase 1/2 Unknown